Back to search

Article

Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease

2021-12-07

Abstract excerpt

Symptoms after SARS-CoV-2 primary vaccination among patients with inflammatory bowel disease (IBD) are generally of similar frequency, severity, and duration to those reported in the general population. The symptom profile after a 3 rd mRNA vaccine dose in the predominantly immune-compromised IBD population is unknown. We aimed to assess symptomology after a 3 rd or booster dose of mRNA vaccination in adults with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8f83859b-be04-56fe-b1b0-76bd4568a3d5
DOI
10.1101/2021.12.05.21266089
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel DiseaseDOI 10.1101/2021.12.05.21266089
Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel DiseaseSemantic proximity
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional studySemantic proximity
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS – CoV ‐2 Messenger RNA VaccinationSemantic proximity
Investigating the Association between the COVID-19 Vaccination and Incident Gastrointestinal Symptomology: A Comprehensive DatasetSemantic proximity
Influence of the COVID-19 Outbreak on Health-Related Quality of Life in Inflammatory Bowel Disease Patients in China: A Cross-Sectional Questionnaire-Based StudySemantic proximity
Patients with Inflammatory Bowel Disease on anti-Tumor Necrosis Factor Therapy Might be Predisposed to SARS-CoV-2 Variants Infection Even after Receiving a Third mRNA Vaccine DoseSemantic proximity
Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective StudySemantic proximity
COVID-19 Vaccine Booster Dose Willingness Among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional StudySemantic proximity
Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel DiseaseSemantic proximity
Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccinesSemantic proximity
COVID-19 Vaccine-Induced Antibody and T Cell Responses in Immunosuppressed Patients with Inflammatory Bowel Disease After the Third Vaccine DoseSemantic proximity
Select a neighboring publication to make it the new centre.